Northern Trust Corp Finch Therapeutics Group, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.75 - $51.3 $19,278 - $565,120	11,016 Added 77.34%	25,259 $42,000
Q2 2022 Aug 12, 2022	SELL	$1.91 - $5.11 $96,603 - $258,453	-50,578 Reduced 78.03%	14,243 $40,000
Q1 2022 May 13, 2022	SELL	$5.02 - $10.47 $13,172 - $27,473	-2,624 Reduced 3.89%	64,821 $326,000
Q4 2021 Feb 08, 2022	SELL	$8.95 - $16.88 $16,539 - $31,194	-1,848 Reduced 2.67%	67,445 $672,000
Q3 2021 Nov 15, 2021	SELL	$12.2 - $16.75 $82,533 - $113,313	-6,765 Reduced 8.89%	69,293 $901,000
Q2 2021 Aug 13, 2021	BUY	$12.03 - $17.51 $914,977 - $1.33 Million	76,058 New	76,058 $1.07 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $563M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.